Ruiz Nicolás Idárraga, Herrera Giron Carlota G, Arragan Lezama Carlos Alejandro, Frias Redroban Sergio José, Ventura Herrera Manuel Omar, Sanic Coj Gustavo Adolfo
Surgery, Universidad de Manizales, Ibagué, COL.
General Practice, Facultad Mexicana de Medicina, Universidad La Salle, Mexico City, MEX.
Cureus. 2025 Jun 15;17(6):e86104. doi: 10.7759/cureus.86104. eCollection 2025 Jun.
Managing the gut microbiome with a personalized approach can significantly improve surgical outcomes, leading to reduced risk of infections, improved immune function, faster recovery and healing, and decreased risk of postoperative complications. This review explores microbiome-based interventions, such as probiotics, prebiotics, synbiotics, and fecal microbiota transplantation, and their roles in perioperative, preoperative, and postoperative care. Electronic databases, such as PubMed, ScienceDirect, and Google Scholar, were searched using topic-related keywords and MeSH terms. The literature search was limited to English-language peer-reviewed articles within the last 10 years, but the majority of the literature was from the last five years. Microbiome interventions have been associated with reduced postoperative complications and enhanced recovery times. The study found that changing the gut microbiome in specific ways, like using probiotics and synbiotics before and after surgery, can lead to better surgical results. For example, these treatments can lower the risk of infection at the surgery site by 40%-80% compared to standard care, help patients recover their bowel function one to two days faster, and reduce hospital stays by up to 30%. They also decrease levels of important inflammation markers like IL-6 and CRP. Using probiotics and synbiotics before surgery and continuing them for two weeks can lower infection rates and enhance recovery while managing inflammation. The beneficial effects of probiotics, prebiotics, and synbiotics support their use as effective strategies in perioperative care. However, people react differently to probiotics, prebiotics, and synbiotics because of factors like genetics, age, hormonal differences between sexes, and variations in gut microbiota based on race. Future research should focus on developing personalized microbiome-based interventions and establishing standardized protocols tailored to individual patient characteristics to enhance their effectiveness.
采用个性化方法管理肠道微生物群可显著改善手术效果,降低感染风险,改善免疫功能,加快恢复和愈合速度,并降低术后并发症风险。本综述探讨了基于微生物群的干预措施,如益生菌、益生元、合生元和粪便微生物群移植,以及它们在围手术期、术前和术后护理中的作用。使用与主题相关的关键词和医学主题词(MeSH)搜索了电子数据库,如PubMed、ScienceDirect和谷歌学术。文献搜索仅限于过去10年内的英文同行评审文章,但大多数文献来自过去5年。微生物群干预与降低术后并发症和缩短恢复时间有关。研究发现,以特定方式改变肠道微生物群,如在手术前后使用益生菌和合生元,可带来更好的手术效果。例如,与标准护理相比,这些治疗可将手术部位感染风险降低40%-80%,帮助患者肠道功能恢复快1至2天,并将住院时间缩短多达30%。它们还可降低重要炎症标志物如IL-6和CRP的水平。术前使用益生菌和合生元并持续两周可降低感染率,促进恢复并控制炎症。益生菌、益生元和合生元的有益作用支持它们作为围手术期护理的有效策略使用。然而,由于遗传、年龄、性别激素差异以及基于种族的肠道微生物群差异等因素,人们对益生菌、益生元和合生元的反应各不相同。未来的研究应侧重于开发基于个性化微生物群的干预措施,并建立针对个体患者特征的标准化方案,以提高其有效性。